When Clot Is Tumor: A Roadmap to Anticoagulation in Renal Cell Carcinoma With Tumor Thrombus
- PMID: 36444233
- PMCID: PMC9700246
- DOI: 10.1016/j.jaccao.2022.10.005
When Clot Is Tumor: A Roadmap to Anticoagulation in Renal Cell Carcinoma With Tumor Thrombus
Keywords: epidemiology; renal cell cancer; thrombosis; treatment.
Conflict of interest statement
Dr Hsu holds equity in AbbVie Inc. Dr. Haas is a consultant to Pfizer, Merck Sharp & Dohme, Calithera Biosciences, Eisai, Exelixis, AVEO, and Roche/Genentech.
Comment on
References
-
- Marcoux C., Al Ghamdi S., Manos D., Keating M.-M., Shivakumar S.P. Natural history of tumor thrombus: a single-centre retrospective study. Blood. 2019;134:430.
-
- Kar S.P., Bhosale P., Overman M.J., et al. Role of anticoagulation (AC) in patients with advanced pancreatic cancer (APC) with splanchnic venous thrombosis (SVT) J Clin Oncol. 2011;29(15 suppl) e14622-e14622.
Publication types
LinkOut - more resources
Full Text Sources
